Aceto corporation

Other-Pharmaceuticals

ACET


200 Clarendon Street
Boston , MA 02116

Executive/
Director

Price

  • Last Close
  • $ 1
    $ +0.02 2.04 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.45 - $1.11
  • YTD
  • 0%

  • Trading Volume
  • 12,706
  • Market Cap Full
  • $ 43.2M
  • Shares Outstanding
  • 43.2M
    Nov 6, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 -27.7% -25.8% -79.8% -5% -3.7% 14.2% -35.6% 23.8% 3% -
Q2 -1.9% -53% -25% 4% -21.8% -26.9% -57.8% -44.2% - -
Q3 -26.8% -31.5% -12.3% 8% -23.8% -2.6% -43.6% -1.3% - -
Q4 -11.1% -62.3% -83.1% 10.9% 123.1% -37.1% 44.3% -27% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 3% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -18%-52%-92%1142%31%28%-49%-79%-49%3%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 - - - - -0.82 0.1 -0.72
Q2 - - - - -0.34 -0.56 -0.75
Q3 - - - - -0.44 -0.53 -1.16
Q4 - - - - -0.4 -0.71 -
A 0 0 0 0 -2 -1.7 -2.63

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 28.1 36.4 31.8 39.9 43
Jun 28 35.7 36.4 31.8 40 43
Sep 28 36.2 36.5 31.8 40 43.1
Dec 28.1 36.4 19.6 32 42.9 43.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.8 0.6 1.8 - -
Total Asset Turnover 0.1 - 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 24.3 -61 19.5 42.5 20
Equity multiplier 0.1 0.1 0.1 - -